Joan S Hooper, the SVP & CFO of $ITRI, sold 15,293 shares of the company on 02-19-2026 for an estimated $1,522,242. We received data on the trade from a recent SEC filing. This was a sale of approximately 11.0% of their shares of this class of stock. Following this trade, they now own 124,196 shares of this class of $ITRI stock.
$ITRI Insider Trading Activity
$ITRI insiders have traded $ITRI stock on the open market 25 times in the past 6 months. Of those trades, 0 have been purchases and 25 have been sales.
Here’s a breakdown of recent trading of $ITRI stock by insiders over the last 6 months:
- JOAN S HOOPER (SVP & CFO) has made 0 purchases and 3 sales selling 17,211 shares for an estimated $1,735,277.
- JOHN F. MARCOLINI (SVP, Networked Solutions) has made 0 purchases and 3 sales selling 8,066 shares for an estimated $815,759.
- DONALD L. III REEVES (SVP, Outcomes) has made 0 purchases and 5 sales selling 7,028 shares for an estimated $710,502.
- JUSTIN K PATRICK (SVP, Device Solutions) has made 0 purchases and 3 sales selling 5,697 shares for an estimated $575,919.
- CHRISTOPHER E. WARE (SVP, GC & Corp. Secretary) has made 0 purchases and 3 sales selling 5,180 shares for an estimated $523,614.
- LAURIE ANN PULATIE-HAHN (SVP, HR) has made 0 purchases and 4 sales selling 4,115 shares for an estimated $412,921.
- THOMAS DEITRICH (President & CEO) has made 0 purchases and 2 sales selling 3,536 shares for an estimated $392,684.
- DAVID MARSHALL WRIGHT (VP, Corp. Controller & CAO) has made 0 purchases and 2 sales selling 210 shares for an estimated $23,319.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ITRI Hedge Fund Activity
We have seen 194 institutional investors add shares of $ITRI stock to their portfolio, and 299 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,387,292 shares (-83.0%) from their portfolio in Q4 2025, for an estimated $128,823,935
- MACQUARIE GROUP LTD removed 764,826 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $71,021,742
- HANDELSBANKEN FONDER AB removed 654,711 shares (-65.5%) from their portfolio in Q4 2025, for an estimated $60,796,463
- JPMORGAN CHASE & CO removed 553,146 shares (-81.9%) from their portfolio in Q4 2025, for an estimated $51,365,137
- GOLDMAN SACHS GROUP INC removed 441,197 shares (-43.8%) from their portfolio in Q4 2025, for an estimated $40,969,553
- BNP PARIBAS FINANCIAL MARKETS removed 378,208 shares (-60.9%) from their portfolio in Q4 2025, for an estimated $35,120,394
- SOROS FUND MANAGEMENT LLC added 375,219 shares (+inf%) to their portfolio in Q4 2025, for an estimated $34,842,836
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ITRI Revenue
$ITRI had revenues of $571.7M in Q4 2025. This is a decrease of -6.72% from the same period in the prior year.
You can track ITRI financials on Quiver Quantitative's ITRI stock page.
$ITRI Analyst Ratings
Wall Street analysts have issued reports on $ITRI in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 02/18/2026
- JP Morgan issued a "Overweight" rating on 10/16/2025
To track analyst ratings and price targets for $ITRI, check out Quiver Quantitative's $ITRI forecast page.
$ITRI Price Targets
Multiple analysts have issued price targets for $ITRI recently. We have seen 5 analysts offer price targets for $ITRI in the last 6 months, with a median target of $130.0.
Here are some recent targets:
- Noah Kaye from Oppenheimer set a target price of $133.0 on 02/18/2026
- Ben Kallo from Baird set a target price of $128.0 on 02/18/2026
- Martin Malloy from Johnson Rice set a target price of $130.0 on 01/05/2026
- Mark Strouse from JP Morgan set a target price of $155.0 on 10/16/2025
- Tommy Moll from Stephens & Co. set a target price of $130.0 on 10/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
